The successful management of an elderly Covid-19 infected patient by plasmapheresis

Coronavirus disease 2019 (COVID-19) is a pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China since December 2019. The epidemic spread rapidly worldwide, became a global threat and was characterized as a pandemic on March 11, 2020 by World Health Organization (WHO) [1]. It is not just a viral pneumonia, it can also cause a multisystemic disorder called COVID-19 immune syndrome [2]. In severe COVID-19 patients it was reported that the pro-inflammatory cytokins, mainly IL-6, IL-10, TNF- α were significantly increased around 7-14 days after onset, named as cytokine storm, which is also associated with the aggravation of disease and higher mortality [3,4].

Source: Transfusion and Apheresis Science - August 24, 2020 Category: Hematology Authors: Yasemin Akkoyunlu, Guven Cetin, Sibel Bolukcu, Gulay Okay, Hamza Ogun, Bulent Durdu, Fatmanur Okyaltirik, Kazim Karaslan Tags: Letter to the Editor Source Type: research